Indication

Non-familial Hypercholesterolemia

1 clinical trial

1 product

Clinical trial

A Multicentre, Randomized, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in the Stable Treatment of Patients With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia .

Status: Completed, Estimated PCD: 2023-05-23

Product